Nutranomics Acquires Worldwide Exclusive Licence to GenEpic™ Prostate Cancer …

Nutranomics Acquires Worldwide Exclusive Licence to GenEpic™ Prostate Cancer …

… LLC ("Genesar") to acquire the worldwide exclusive marketing and distributing rights to GenEpic™, a natural therapeutic treatment formula currently the subject of an IRB reviewed (FDA regulated) phase II human clinical study on prostate cancer

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.